Aptose Biosciences Inc. (APTO) Share-based Payment Arrangement, Expense USD 2017 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Aptose Biosciences Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2017 to 2024.
  • Aptose Biosciences Inc. Share-based Payment Arrangement, Expense for the quarter ending March 31, 2024 was $809 K, a 56.8% decline year-over-year.
  • Aptose Biosciences Inc. Share-based Payment Arrangement, Expense for the twelve months ending March 31, 2024 was $2.59 M, a 43.3% decline year-over-year.
  • Aptose Biosciences Inc. annual Share-based Payment Arrangement, Expense for 2023 was $3.65 M, a 29.8% decline from 2022.
  • Aptose Biosciences Inc. annual Share-based Payment Arrangement, Expense for 2022 was $5.21 M, a 59.8% decline from 2021.
  • Aptose Biosciences Inc. annual Share-based Payment Arrangement, Expense for 2021 was $12.9 M, a 39.6% decline from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $2.59 M $809 K -$1.07 M -56.8% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $3.65 M $411 K -$450 K -52.3% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-26
Q3 2023 $4.1 M $599 K -$454 K -43.1% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $4.56 M $769 K -$10 K -1.28% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $4.57 M $1.87 M -$640 K -25.5% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 $5.21 M $861 K -$1.45 M -62.8% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-26
Q3 2022 $6.66 M $1.05 M -$775 K -42.4% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $7.44 M $779 K -$1.39 M -64% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 $8.82 M $2.51 M -$4.13 M -62.2% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-08
Q4 2021 $12.9 M $2.31 M -$2.12 M -47.8% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-24
Q3 2021 $15.1 M $1.83 M -$3.08 M -62.7% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-01
Q2 2021 $18.1 M $2.16 M -$5.54 M -71.9% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-02
Q1 2021 $23.7 M $6.64 M +$2.24 M +50.9% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q4 2020 $21.4 M $4.43 M +$3.87 M +688% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-22
Q3 2020 $17.6 M $4.91 M +$4.4 M +873% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 $13.2 M $7.7 M +$7.13 M +1256% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-03
Q1 2020 $6.04 M $4.4 M +$3.74 M +565% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-04
Q4 2019 $2.3 M $562 K -$20 K -3.44% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-23
Q3 2019 $2.32 M $504 K -$447 K -47% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-10
Q2 2019 $2.76 M $568 K +$53 K +10.3% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-04
Q1 2019 $2.71 M $662 K -$1.57 M -70.3% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-05
Q4 2018 $4.28 M $582 K Oct 1, 2018 Dec 31, 2018 10-K 2020-03-10
Q3 2018 $951 K +$796 K +514% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-05
Q2 2018 $515 K +$66 K +14.7% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-06
Q1 2018 $2.23 M Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-07
Q3 2017 $155 K Jul 1, 2017 Sep 30, 2017 8-K 2019-03-12
Q2 2017 $449 K Apr 1, 2017 Jun 30, 2017 8-K 2019-03-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.